Milestone Scientific Strengthens Leadership with New Board Appointment
Milestone Scientific Expands Leadership Team with New Director
Milestone Scientific Inc. (NYSE: MLSS), a pioneer in computerized drug delivery systems, is excited to announce the appointment of Shanth Thiyagalingam to its Board of Directors. This strategic move comes amidst the company's growth trajectory in developing innovative solutions for painless and accurate medical injections.
Welcoming a Leader in Medical Technology
Shanth Thiyagalingam, an accomplished medtech executive with two decades of comprehensive experience, commenced his role on May 14, 2025. His expertise spans commercial scaling, product innovation, and strategic execution, making him a valuable asset to Milestone Scientific during this period of expansion.
Driving Innovation in Injection Technologies
The addition of Mr. Thiyagalingam to the Board aligns with Milestone Scientific’s strategy aimed at enhancing adoption of its advanced CompuFlo® Epidural System. This system is particularly significant given the recent assignment of favorable Medicare Part B payment rates, allowing for broader access to patients requiring these procedures. The strategic initiatives empowered by Mr. Thiyagalingam will help facilitate the deployment of the Federal Supply Schedule (FSS) contract.
A Proven Track Record
Neal Goldman, Chairman and Interim CEO of Milestone Scientific, expressed enthusiasm at the appointment, highlighting Mr. Thiyagalingam's proven leadership in expanding high-growth medical device companies. His extensive background in reimbursement strategies and commercial execution will be essential as Milestone transitions into its next growth phase.
Shanth Thiyagalingam’s Career Highlights
Currently serving as the CEO of PainTEQ, which specializes in proprietary medical devices for pain therapy, Mr. Thiyagalingam has spearheaded the transformation of the organization from startup to highly recognized innovator. His achievements include leading mergers and acquisitions and obtaining essential CPT code approvals to facilitate groundbreaking pain therapies.
Global Experience
Prior to his leadership at PainTEQ, Mr. Thiyagalingam was General Manager for APAC Neuromodulation at Abbott. There, he directed commercial operations and strategy across multiple regions, including the Asia-Pacific, introducing innovative solutions that have navigated complex market landscapes. His role was pivotal in establishing successful product launches and regional expansions.
A Commitment to Excellence
Mr. Thiyagalingam began his career at Stryker and St. Jude Medical, where he managed key portfolios and achieved significant business growth. He holds a Bachelor of Medical Science, a Master’s in Marketing Management, and an MBA, all of which underscore his commitment to excellence in the medtech sector.
About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) focuses on the development of advanced injection technologies designed to improve patient care. Utilizing its proprietary DPS Dynamic Pressure Sensing Technology, Milestone Scientific aims to elevate the standards of safety and efficacy in medical and dental applications, ensuring that injections are not only precise but also comfortable for patients.
Commitment to Innovation
With a robust portfolio of products, Milestone Scientific continues to push the boundaries of what's possible in the medical technology space, enhancing the overall patient experience through innovative technology and dedication to research. To learn more about their initiatives, please visit their official website.
Frequently Asked Questions
What position has Shanth Thiyagalingam been appointed to at Milestone Scientific?
Shanth Thiyagalingam has been appointed to the Board of Directors at Milestone Scientific Inc.
What are the qualifications of Shanth Thiyagalingam?
He holds a Bachelor of Medical Science and an MBA, boasting over 20 years of leadership experience in the medical device industry.
What technology is Milestone Scientific known for?
Milestone Scientific is known for its computerized drug delivery instruments, particularly the CompuFlo® Epidural System.
Why is this appointment significant for Milestone Scientific?
This appointment aligns with the company's goals of broadening access to its products, particularly through strategic initiatives tied to Medicare payments and FSS contracts.
How does Milestone Scientific impact patient care?
The company focuses on innovative technologies that enhance the precision and comfort of injections, significantly improving the patient experience.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to [email protected].
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.